Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1.
Journal: Science immunology
Published: November 17, 2023
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma.
Journal: Gastroenterology
Published: September 07, 2023
Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins.
Journal: Nature immunology
Published: June 06, 2023
Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice.
Journal: Nature communications
Published: November 16, 2022
Determinants of Homologous Recombination Deficiency in Pancreatic Cancer.
Journal: Cancers
Published: August 06, 2021
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 10, 2021
A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma.
Journal: Molecular cancer therapeutics
Published: July 23, 2020
Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle.
Journal: Seminars in cancer biology
Published: November 05, 2019
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation.
Journal: British journal of cancer
Published: May 18, 2019
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis.
Journal: The Journal of experimental medicine
Published: April 14, 2019
Last Updated: 09/26/2026